Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer's disease and frontotemporal lobar degeneration
about
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's DiseaseEffects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models.Frontotemporal Lobar Degeneration: Mechanisms and Therapeutic Strategies.Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium.Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease.Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate.MRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance.A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy.Tau aggregation inhibitors: the future of Alzheimer's pharmacotherapy?Neuronal Expression of Truncated Tau Efficiently Promotes Neurodegeneration in Animal Models: Pitfalls of Toxic Oligomer Analysis.Progressive Motor Deficit is Mediated by the Denervation of Neuromuscular Junctions and Axonal Degeneration in Transgenic Mice Expressing Mutant (P301S) Tau Protein.
P2860
Q26739412-11CB6235-EBF4-4466-B532-5F9FF2A5E083Q35558517-F8DA062E-8765-4E39-BED9-D1F9DF1046A4Q38625515-592217F6-1632-4019-90A8-8A6406EC5587Q38715233-E1BDCDDC-57FF-46BC-A685-C8678A939FD0Q38901388-F93FC107-499D-4776-A763-2EEB7D89FD7CQ42407159-04104D99-48D5-45CF-AEF2-E0A79CFDA36EQ46620006-E0A89A20-D581-4011-B7CA-0E7C37ADDA3CQ47548619-8D03E623-03C4-454F-958C-66215C90B449Q48239696-B7068A6B-1C04-4BD6-BA02-C4547DDB7E9FQ50990954-DDA4453C-3F97-443D-B334-3F4561D00D6AQ51129031-14045427-2CDB-4DA8-AE43-E33ED24528D6
P2860
Different pathways of molecular pathophysiology underlie cognitive and motor tauopathy phenotypes in transgenic models for Alzheimer's disease and frontotemporal lobar degeneration
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Different pathways of molecula ...... ntotemporal lobar degeneration
@ast
Different pathways of molecula ...... ntotemporal lobar degeneration
@en
type
label
Different pathways of molecula ...... ntotemporal lobar degeneration
@ast
Different pathways of molecula ...... ntotemporal lobar degeneration
@en
prefLabel
Different pathways of molecula ...... ntotemporal lobar degeneration
@ast
Different pathways of molecula ...... ntotemporal lobar degeneration
@en
P2093
P2860
P1476
Different pathways of molecula ...... ntotemporal lobar degeneration
@en
P2093
C M Wischik
C R Harrington
F Theuring
J E Rickard
K A Harrington
K Davidson
P2860
P2888
P304
P356
10.1007/S00018-014-1804-Z
P577
2014-12-19T00:00:00Z